{"log_id": 315411377807059225, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 0, "average": 0.999676, "min": 0.998185}, "location": {"width": 233, "top": 247, "height": 26, "left": 241}, "words": "神经毒性药物治疗的影响"}, {"probability": {"variance": 4e-06, "average": 0.999181, "min": 0.988683}, "location": {"width": 684, "top": 289, "height": 28, "left": 282}, "words": "通常在接受紫杉醇单药治疗的患者中,神经系统临床症状的发生率和严重程"}, {"probability": {"variance": 0.000144, "average": 0.995111, "min": 0.940723}, "location": {"width": 726, "top": 330, "height": 28, "left": 239}, "words": "度呈剂量依赖性。所有患者中的60%(3%严重),以及先前不存在神经病变的"}, {"probability": {"variance": 2.7e-05, "average": 0.997144, "min": 0.974825}, "location": {"width": 724, "top": 372, "height": 28, "left": 240}, "words": "患者中的52%(2%严重),发生外周神经病变,但通常都不严重。累积剂量会"}, {"probability": {"variance": 0.00032, "average": 0.995326, "min": 0.895479}, "location": {"width": 743, "top": 413, "height": 28, "left": 239}, "words": "增加外周神经病变的发生率。感觉异常通常表现为感觉过敏。在第一个疗程后27%"}, {"probability": {"variance": 4.6e-05, "average": 0.997715, "min": 0.965525}, "location": {"width": 727, "top": 454, "height": 29, "left": 239}, "words": "的患者发生神经系统症状,34%~51%的患者在第2到第10个疗程中发生神经症状"}, {"probability": {"variance": 8e-06, "average": 0.998297, "min": 0.985796}, "location": {"width": 715, "top": 494, "height": 30, "left": 249}, "words": "%的患者由于外周神经病变而终止紫杉醇治疗。感觉神经症状通常在紫杉醇治"}, {"probability": {"variance": 3e-06, "average": 0.998926, "min": 0.989627}, "location": {"width": 725, "top": 536, "height": 28, "left": 238}, "words": "疗停止后几个月内好转或缓解。由于先前治疗而导致的神经病变并不是紫杉醇治"}, {"probability": {"variance": 0, "average": 0.999705, "min": 0.999243}, "location": {"width": 110, "top": 577, "height": 26, "left": 237}, "words": "疗的禁忌症"}, {"probability": {"variance": 5e-06, "average": 0.998458, "min": 0.98909}, "location": {"width": 683, "top": 618, "height": 31, "left": 281}, "words": "在协作组发起的卵巢癌一线治疗临床研究中(见表3),神经毒性包括运动"}, {"probability": {"variance": 4.4e-05, "average": 0.996444, "min": 0.968601}, "location": {"width": 714, "top": 660, "height": 28, "left": 238}, "words": "神经和感觉神经病变。紫杉醇175mg/m2持续3小时输注联合顺铂75mg/m2治疗组"}, {"probability": {"variance": 3.4e-05, "average": 0.997466, "min": 0.969737}, "location": {"width": 724, "top": 701, "height": 27, "left": 240}, "words": "与环磷酰胺联合顺铂治疗组相比,神经毒性,发生率分别为87%(21%严重)和"}, {"probability": {"variance": 2.1e-05, "average": 0.997607, "min": 0.97216}, "location": {"width": 726, "top": 741, "height": 28, "left": 238}, "words": "52%(2%严重)。由于在协作组研究的病例报告表中没有收集不良反应的完全"}, {"probability": {"variance": 1e-06, "average": 0.999192, "min": 0.994017}, "location": {"width": 726, "top": 781, "height": 31, "left": 237}, "words": "缓解的日期,并且只有少数患者有完整的随访材料,所以不能精确确定该研究中"}, {"probability": {"variance": 0.012286, "average": 0.965683, "min": 0.515773}, "location": {"width": 727, "top": 822, "height": 30, "left": 236}, "words": "Il级或Ⅳ级的神经毒性的持续时间。在GOG卵巢癌一线治疗的临床研究中,外"}, {"probability": {"variance": 0.00016, "average": 0.99478, "min": 0.933354}, "location": {"width": 725, "top": 864, "height": 29, "left": 236}, "words": "周神经病变报道为神经毒性。紫杉醇135mg/m24小时输注联合顺铂75mg/m2治疗"}, {"probability": {"variance": 4e-06, "average": 0.998443, "min": 0.992468}, "location": {"width": 725, "top": 905, "height": 27, "left": 236}, "words": "组,与环磷酰胺联合顺铂治疗组相比,神经毒性的发生相似,分别为25%(3%"}, {"probability": {"variance": 3.2e-05, "average": 0.996484, "min": 0.975245}, "location": {"width": 702, "top": 946, "height": 26, "left": 236}, "words": "严重)和20%(0%严重)。协作组研究和GOG研究中的神经毒性作横向比较"}, {"probability": {"variance": 0.004214, "average": 0.975858, "min": 0.671182}, "location": {"width": 788, "top": 973, "height": 46, "left": 235}, "words": "提示当紫杉醇联合顺铂75mg/m2治疗时,紫杉醇175mgm2持续3小时输注与紫杉"}, {"probability": {"variance": 0.000185, "average": 0.995371, "min": 0.919012}, "location": {"width": 724, "top": 1028, "height": 29, "left": 236}, "words": "醇135mg/m24小时输注相比,前者严重的神经毒性更常见,它们的发生率分别"}, {"probability": {"variance": 0, "average": 0.999649, "min": 0.999352}, "location": {"width": 135, "top": 1008, "height": 38, "left": 949}, "words": "广东"}, {"probability": {"variance": 0.036536, "average": 0.839598, "min": 0.514199}, "location": {"width": 187, "top": 1038, "height": 44, "left": 906}, "words": "有限公司"}, {"probability": {"variance": 6.1e-05, "average": 0.994382, "min": 0.977638}, "location": {"width": 111, "top": 1070, "height": 24, "left": 237}, "words": "为21%和3%"}, {"probability": {"variance": 2.8e-05, "average": 0.997204, "min": 0.974511}, "location": {"width": 683, "top": 1110, "height": 29, "left": 278}, "words": "在非小细胞肺癌患者中,紫杉醇联合顺铂治疗,与紫杉醇单药治疗卵巢癌或"}, {"probability": {"variance": 5.8e-05, "average": 0.995787, "min": 0.964639}, "location": {"width": 728, "top": 1149, "height": 29, "left": 234}, "words": "乳腺癌相比,严重的神经毒性发生率更高。紫杉醇135mg/m24小时输注联合顺"}, {"probability": {"variance": 0.008462, "average": 0.97828, "min": 0.429811}, "location": {"width": 725, "top": 1187, "height": 33, "left": 236}, "words": "铂75mg/m2治疗的非小细胞肺癌患者中,13%发生严重的感觉神经症状在接"}, {"probability": {"variance": 6.6e-05, "average": 0.993559, "min": 0.975049}, "location": {"width": 491, "top": 1233, "height": 26, "left": 236}, "words": "受顺铂足叶乙甙的非小细胞肺癌患者中为8%(见表7"}, {"probability": {"variance": 0.000104, "average": 0.647934, "min": 0.63776}, "location": {"width": 81, "top": 1215, "height": 33, "left": 867}, "words": "上海"}, {"probability": {"variance": 0.002582, "average": 0.981718, "min": 0.75172}, "location": {"width": 748, "top": 1270, "height": 41, "left": 275}, "words": "除了外周神经病变以外,紫杉醇治疗后的其他神经系统不良反应较罕见"}, {"probability": {"variance": 0.000845, "average": 0.991302, "min": 0.846498}, "location": {"width": 587, "top": 1312, "height": 29, "left": 245}, "words": "(<1%),包括癫痫大发作、晕厥、共济失调、脑神经元病。"}, {"probability": {"variance": 0, "average": 0.959449, "min": 0.959449}, "location": {"width": 35, "top": 1303, "height": 41, "left": 938}, "words": "小"}, {"probability": {"variance": 0.012898, "average": 0.97195, "min": 0.363155}, "location": {"width": 710, "top": 1355, "height": 28, "left": 276}, "words": "紫杉醇安全性的持续监测还报告了偶见的自主神经疾病导致的麻痹性肠梗"}, {"probability": {"variance": 0.00438, "average": 0.983015, "min": 0.619903}, "location": {"width": 725, "top": 1397, "height": 27, "left": 234}, "words": "阻。视神经和/或视觉障碍(闪光性暗点)也有报道,特别是在那些剂量高于推"}, {"probability": {"variance": 0.000109, "average": 0.995866, "min": 0.940607}, "location": {"width": 725, "top": 1439, "height": 27, "left": 233}, "words": "荐量的患者。这些不良反应通常是可逆的。在文献中,有关于患者视觉诱发电位"}], "language": 3}